Related Experiment Video
Updated: Aug 10, 2026

11:14
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers
S H Weiss1, J J Goedert, S Gartner
1Department of Preventive Medicine, New Jersey Medical School, Newark 07103.
Summary
A laboratory worker contracted human immunodeficiency virus type 1 (HIV-1) infection, likely through undetected skin contact with concentrated virus. This highlights the risk of prolonged laboratory exposure to HIV-1, even with Biosafety Level 3 containment.
Area of Science:
- Virology
- Occupational Health
- Infectious Diseases
Background:
- Occupational exposure to human immunodeficiency virus type 1 (HIV-1) poses a risk to laboratory personnel.
- Previous studies have documented HIV-1 transmission through needlestick injuries and other parenteral exposures.
Purpose of the Study:
- To investigate the risk of HIV-1 infection among laboratory workers with potential occupational exposure.
- To assess the effectiveness of Biosafety Level 3 containment in preventing HIV-1 transmission in a laboratory setting.
Main Methods:
- A prospective cohort study was conducted involving 265 laboratory and affiliated workers.
- Molecular analyses were performed on HIV-1 isolates from an infected worker and compared to known strains.
- Incidence rates of HIV-1 infection were calculated based on duration and type of exposure.
Main Results:
- One worker, with no known risk factors, tested HIV-1 seropositive at study entry.
- Molecular analysis revealed the HIV-1 isolate was indistinguishable from a known laboratory strain (H9/HTLV-IIIB).
- The incidence rate of HIV-1 infection was 0.48 per 100 person-years of exposure, comparable to healthcare workers with needlestick injuries.
Conclusions:
- Prolonged laboratory exposure to concentrated HIV-1 poses a risk of infection, potentially through undetected skin contact.
- Strict adherence to Biosafety Level 3 containment and practices is crucial when handling concentrated HIV-1.
- Further refinement of laboratory safety procedures may be necessary to minimize occupational HIV-1 transmission risk.
Related Concept Videos
Standard Precaution
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...

